Kaminker J.S., Zhang Y., Waugh A., Haverty P.M., Peters B., Sebisanovic D., Stinson J., Forrest W.F., Bazan J.F., Seshagiri S., Zhang Z. (2007). Distinguishing cancer-associated missense mutations from common polymorphisms. Cancer Research 67, 465-73.[PubMed]
Training Data
Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C., Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S., et al. (2007). Patterns of somatic mutation in human cancer genomes. Nature 446, 153-158.[Pubmed]
Sjoblom, T., Jones, S., Wood, L. D., Parsons, D. W., Lin, J., Barber, T. D., Mandelker, D., Leary, R. J., Ptak, J., Silliman, N., et al. (2006). The consensus coding sequences of human breast and colorectal cancers. Science 314, 268-274.[PubMed]
Davies, H., Hunter, C., Smith, R., Stephens, P., Greenman, C., Bignell, G., Teague, J., Butler, A., Edkins, S., Stevens, C., et al. (2005). Somatic mutations of the protein kinase gene family in human lung cancer. Cancer Res 65, 7591-7595.[PubMed]
Stephens, P., Edkins, S., Davies, H., Greenman, C., Cox, C., Hunter, C., Bignell, G., Teague, J., Smith, R., Stevens, C., et al. (2005). A screen of the complete protein kinase gene family identifies diverse patterns of somatic mutations in human breast cancer. Nat Genet 37, 590-592.[PubMed]
Parsons, D. W., Wang, T. L., Samuels, Y., Bardelli, A., Cummins, J. M., DeLong, L., Silliman, N., Ptak, J., Szabo, S., Willson, J. K., et al. (2005). Colorectal cancer: mutations in a signalling pathway. Nature 436, 792.[PubMed]
Stephens, P., Hunter, C., Bignell, G., Edkins, S., Davies, H., Teague, J., Stevens, C., O'Meara, S., Smith, R., Parker, A., et al. (2004). Lung cancer: intragenic ERBB2 kinase mutations in tumours. Nature 431, 525-526.[PubMed]
Wang, Z., Shen, D., Parsons, D. W., Bardelli, A., Sager, J., Szabo, S., Ptak, J., Silliman, N., Peters, B. A., van der Heijden, M. S., et al. (2004). Mutational analysis of the tyrosine phosphatome in colorectal cancers. Science 304, 1164-1166.[PubMed]
Samuels, Y., Wang, Z., Bardelli, A., Silliman, N., Ptak, J., Szabo, S., Yan, H., Gazdar, A., Powell, S. M., Riggins, G. J., et al. (2004). High frequency of mutations of the PIK3CA gene in human cancers. Science 304, 554.[PubMed]
Paez, J. G., Janne, P. A., Lee, J. C., Tracy, S., Greulich, H., Gabriel, S., Herman, P., Kaye, F. J., Lindeman, N., Boggon, T. J., et al. (2004). EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy. Science 304, 1497-1500.[PubMed]
Lynch, T. J., Bell, D. W., Sordella, R., Gurubhagavatula, S., Okimoto, R. A., Brannigan, B. W., Harris, P. L., Haserlat, S. M., Supko, J. G., Haluska, F. G., et al. (2004). Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. N Engl J Med 350, 2129-2139.[PubMed]
Bardelli, A., Parsons, D. W., Silliman, N., Ptak, J., Szabo, S., Saha, S., Markowitz, S., Willson, J. K., Parmigiani, G., Kinzler, K. W., et al. (2003). Mutational analysis of the tyrosine kinome in colorectal cancers. Science 300, 949.[PubMed]
Davies, H., Bignell, G. R., Cox, C., Stephens, P., Edkins, S., Clegg, S., Teague, J., Woffendin, H., Garnett, M. J., Bottomley, W., et al. (2002). Mutations of the BRAF gene in human cancer. Nature 417, 949-954.[PubMed]
Mathe, E., Olivier, M., Kato, S., Ishioka, C., Hainaut, P., and Tavtigian, S. V. (2006). Computational approaches for predicting the biological effect of p53 missense mutations: a comparison of three sequence analysis based methods. Nucleic Acids Res 34, 1317-1325.[PubMed]
Greenman, C., Wooster, R., Futreal, P. A., Stratton, M., and Easton, D. (2006). Statistical Analysis of Pathogenicity of Somatic Mutations in Cancer. Genetics.[PubMed]
Yue, P., Li, Z., and Moult, J. (2005). Loss of protein structure stability as a major causative factor in monogenic disease. J Mol Biol 353, 459-473.[PubMed]
Yue, P., Melamud, E., and Moult, J. (2006). SNPs3D: Candidate Gene and SNP selection for Association Studies. BMC Bioinformatics 7, 166.[PubMed]
Yue, P., and Moult, J. (2006). Identification and analysis of deleterious human SNPs. J Mol Biol 356, 1263-1274.[PubMed]
Karchin, R., Diekhans, M., Kelly, L., Thomas, D. J., Pieper, U., Eswar, N., Haussler, D., and Sali, A. (2005). LS-SNP: large-scale annotation of coding non-synonymous SNPs based on multiple information sources. Bioinformatics 21, 2814-2820.[PubMed]
Clifford, R. J., Edmonson, M. N., Nguyen, C., and Buetow, K. H. (2004). Large-scale analysis of non-synonymous coding region single nucleotide polymorphisms. Bioinformatics 20, 1006-1014.[PubMed]
Barenboim, M., Jamison, D. C., and Vaisman, II (2005). Statistical geometry approach to the study of functional effects of human nonsynonymous SNPs. Hum Mutat 26, 471-476.[PubMed]
Bao, L., and Cui, Y. (2005). Prediction of the phenotypic effects of non-synonymous single nucleotide polymorphisms using structural and evolutionary information. Bioinformatics 21, 2185-2190.[PubMed]
Krishnan, V. G., and Westhead, D. R. (2003). A comparative study of machine-learning methods to predict the effects of single nucleotide polymorphisms on protein function. Bioinformatics 19, 2199-2209.[PubMed]
Ng, P. C., and Henikoff, S. (2003). SIFT: Predicting amino acid changes that affect protein function. Nucleic Acids Res 31, 3812-3814.[PubMed]
Forbes, S., Clements, J., Dawson, E., Bamford, S., Webb, T., Dogan, A., Flanagan, A., Teague, J., Wooster, R., Futreal, P. A., and Stratton, M. R. (2006). Cosmic 2005. Br J Cancer 94, 318-322.[PubMed]
Bamford, S., Dawson, E., Forbes, S., Clements, J., Pettett, R., Dogan, A., Flanagan, A., Teague, J., Futreal, P. A., Stratton, M. R., and Wooster, R. (2004). The COSMIC (Catalogue of Somatic Mutations in Cancer) database and website. Br J Cancer 91, 355-358.[PubMed]
Futreal, P. A., Coin, L., Marshall, M., Down, T., Hubbard, T., Wooster, R., Rahman, N., and Stratton, M. R. (2004). A census of human cancer genes. Nat Rev Cancer 4, 177-183.[PubMed]
Bardelli, A., and Velculescu, V. E. (2005). Mutational analysis of gene families in human cancer. Curr Opin Genet Dev 15, 5-12.[PubMed]
Di Nicolantonio, F., and Bardelli, A. (2006). Kinase mutations in cancer: chinks in the enemy's armour?. Curr Opin Oncol 18, 69-76.[PubMed]
Futreal, P. A., Wooster, R., and Stratton, M. R. (2005). Somatic mutations in human cancer: insights from resequencing the protein kinase gene family. Cold Spring Harb Symp Quant Biol 70, 1-8.[PubMed]
Benvenuti, S., Arena, S., and Bardelli, A. (2005). Identification of cancer genes by mutational profiling of tumor genomes. FEBS Lett 579, 1884-1890.[PubMed]
Weir, B., Zhao, X., and Meyerson, M. (2004). Somatic alterations in the human cancer genome. Cancer Cell 6, 433-438.[PubMed]